A 39-year-old woman with unilateral metamorphosias
Main Article Content
Abstract
A 39-year-old white woman presented to the Centro Hospitalar Vila Nova de Gaia with a chief symptom of blurred vision and metamorphopsias in the left eye of several days' duration. Her past medical history was unremarkable. She was not taking any medications. She was a nonsmoker, did not use alcohol, and had no pets. Her family history was unremarkable except for her mother having hypertension.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Neri P. New Trends in the management of inflammatory choroidal neovascularisation. European Ophthalmic Review 2009;3:93-7.
Essex R, Wong J, Fraser-Bell S, Sandbach J, Tufail A, Bird A, Dowler J. Punctate inner choroidopathy. Arch of Ophthalmol 2010;128:982-7.
Watzke R, Packer A, Folk J, Benson W, Burgess D, Ober R. Punctate inner choroidopathy. Am J Ophthalmol 1984;98:572-84.
Amer R, Lois N. Punctate inner choroidopathy. Surv Ophthalmol 2011;56:36-53.
Gerstenblith A, Thorne J, Sobrin L, Do D, Shah S, Foster S, Jacobs D, Nguyen Q. Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology 2007;114:1201-4.
Brown J, Folk J, Reddy C, Kimura A. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome Ophthalmol 1996;103:1100-5.
Menezo V, Cuthbertson F, Susan D. Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy. Retina 2010;30. [Epub ahead of print]
Brueggeman R, Noffke A, Jampol L. Resolution of punctuate inner choroidopathy lesions with oral prednisone therapy. Arch Ophthalmol 2002; 120:996.
Levy J, Shneck M, Klemperer I, Lifshitz T. Punctate inner choroidopathy: resolution after oral steroid treatment and review of the literature. Can J Ophthalmol 2005;40:605-8.
Sim D, Sheth H, Kaines A, Tufail A. Punctate inner choroidopathy-associated choroidal neovascular membranes during pregnancy. Eye 2008;22:725-7.
Cirino A, Mathura J, Jampol L. Resolution of activity (choroiditis and choroidal neovascularization) of chronic recurrent punctate inner choroidopathy after treatment with interferon B-1A. Retina 2006;26:1091-2.
Olsen TW, Capone A Jr, Sternberg P Jr, Grossniklaus HE, Martin DF, Aaberg TM Sr. Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical managment and pathological findings. Ophthalmol 1996;103:2061-9.
Chatterjee S, Gibson J. Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol 2003;87:925-7.
Chan WM, Lai T, Liu D, Lam D. Intravitreal Bevacizumab (Avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy or of idiopathic origin. Am J Ophthalmol 2007; 143: 977-83.
Vossmerbaeumer U, Spandau U, Baltz S, Wickenhaeuser A, Jonas J. Intravitreal bevacizumab for choroidal neovascularisation secondary to punctate inner choroidopathy. Clin Experiment Ophthalmol 2008;36:292-4.
Kramer M, Axer-Siegel R, Jaouni T, Reich E, Hemo I, Priel E, Averbukh E, Ehrlich R, Chowers I, Weinberger D, Amer R. Bevacizumab for choroidal neovascularization related to inflammatory diseases. Retina 2010;30:938-44.
Spiteri Cornish K, William GJ, Gavin MP, Imrie FR. Visual and optical coherence tomography outcomes of intravitreal bevacizumab and ranibizumab in inflammatory choroidal neovascularization secondary to punctuate inner choroidopathy. Eur J Ophthalmol 2011; 21:440-5.